Biological monitoring in workers in a nitrobenzene reduction plant: haemoglobin versus serum albumin adducts.

Article Details

Citation

Copy to clipboard

Thier R, Lewalter J, Selinski S, Bolt HM

Biological monitoring in workers in a nitrobenzene reduction plant: haemoglobin versus serum albumin adducts.

Int Arch Occup Environ Health. 2001 Sep;74(7):483-8.

PubMed ID

11697451 [ View in PubMed

]

Abstract

The high priority of monitoring workers exposed to nitrobenzene is a consequence of clear findings of experimental carcinogenicity of nitrobenzene and the associated evaluations by the International Agency for Research on Cancer. Eighty male employees of a nitrobenzene reduction plant, with potential skin contact with nitrobenzene and aniline, participated in a current medical surveillance programme. Blood samples were routinely taken and analysed for aniline, 4-aminodiphenyl (4-ADP) and benzidine adducts of haemoglobin (Hb) and human serum albumin (HSA). Also, levels of methaemoglobin (Met-Hb) and of carbon monoxide haemoglobin (CO-Hb) were monitored. Effects of smoking were straightforward. Using the rank sum test of Wilcoxon, we found that very clear-cut and statistically significant smoking effects (about 3-fold increases) were apparent on CO-Hb (P = 0.00085) and on the Hb adduct of 4-ADP (P = 0.0006). The mean aniline-Hb adduct level in smokers was 1.5 times higher than in non-smokers; the significance (P = 0.05375) was close to the 5% level. The strongest correlation was evident between the Hb and HSA adducts of aniline (r(s) = 0.846). Less pronounced correlations (but with P values < 0.02) appeared between aniline-Hb and 4-ADP-Hb adducts (r(s) = 0.388), between 4-ADP and 4-ADP-HSA adducts (r(s) = 0.373), and between 4-ADP-Hb and aniline-HSA adducts (r(s) = 0.275). In view of the proposal for additional use of the aniline-HSA adduct for biological monitoring, particularly in cases of acute overexposures or poisonings, the strong correlation of the Hb and HSA conjugates is noteworthy; the ratio aniline-HSA:aniline-Hb was 1:42 for the entire cohort.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Aniline	Serum albumin	Protein	Humans	Unknown	Not Available	Details